Sara Nordentoft
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Nordentoft has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Karin Piil
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet , Copenhagen
11 shared publications - Rikke Guldager
Department of Neurosurgery Copenhagen University Hospital – Rigshospitalet Copenhagen Denmark
8 shared publications - Helle Pappot
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
4 shared publications - Lena Aadal
Hammel Neurorehabilitation Centre and University Research Clinic, Aarhus University, Hammel, Central Denmark Region, Denmark
4 shared publications - Tiit Mathiesen
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
4 shared publications - Florien Willemijn Boele
Leeds Institute of Medical Research at St James’s, St James’s University Hospital, University of Leeds , Leeds
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
Breaking barriers and shaping futures: A sequential multi-methods exploration of career pathways for nurses and allied health professionals
Background: Nurses and Allied Health Professionals (AHPs) are essential to neuro-oncology multidisciplinary teams (MDTs) in delivering holistic, person-centered care. Despite their central role, the career development landscape for neuro‑oncology nurses and AHPs remains fragmented, with limited opportunities for structured progression, advanced training, or protected time for professional growth. We aimed to identify key barriers to professional development and generate practical, actionable strategies to build capacity. Methods: We conducted qualitative focus groups with neuro-oncology nurses and AHPs to generate barriers and solutions to career development and progression, followed by a quantitative survey to rank barriers and solutions for priority and feasibility. A rapid qualitative synthesis of focus group findings informed the survey questions, which were analyzed descriptively. Based upon expert consensus, a set of practical and actionable solutions was proposed. Results: Ten nurses and AHPs took part, representing Sweden, Denmark, the United Kingdom, and the Netherlands, and included junior- and senior-level roles. Across 4 topics (variability in education opportunities, the MDT environment, practical barriers, and building the next generation), a total of 23 barriers and 32 solutions were generated in focus groups and then ranked in the survey exercise. Ten action points were generated to guide the strategy of the EANO Nurse and Allied Health Professions Committee. Conclusions: The collective insights of nurses and AHPs from different countries, at different career stages, helped shape a robust strategic action plan. Grounded in real‑world experiences and shared challenges, our results offer a practical roadmap for strengthening capacity and supporting career development.
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
Open AccessBreaking barriers and shaping futures: A sequential multi-methods exploration of career pathways for nurses and allied health professionals
Background: Nurses and Allied Health Professionals (AHPs) are essential to neuro-oncology multidisciplinary teams (MDTs) in delivering holistic, person-centered care. Despite their central role, the career development landscape for neuro‑oncology nurses and AHPs remains fragmented, with limited opportunities for structured progression, advanced training, or protected time for professional growth. We aimed to identify key barriers to professional development and generate practical, actionable strategies to build capacity. Methods: We conducted qualitative focus groups with neuro-oncology nurses and AHPs to generate barriers and solutions to career development and progression, followed by a quantitative survey to rank barriers and solutions for priority and feasibility. A rapid qualitative synthesis of focus group findings informed the survey questions, which were analyzed descriptively. Based upon expert consensus, a set of practical and actionable solutions was proposed. Results: Ten nurses and AHPs took part, representing Sweden, Denmark, the United Kingdom, and the Netherlands, and included junior- and senior-level roles. Across 4 topics (variability in education opportunities, the MDT environment, practical barriers, and building the next generation), a total of 23 barriers and 32 solutions were generated in focus groups and then ranked in the survey exercise. Ten action points were generated to guide the strategy of the EANO Nurse and Allied Health Professions Committee. Conclusions: The collective insights of nurses and AHPs from different countries, at different career stages, helped shape a robust strategic action plan. Grounded in real‑world experiences and shared challenges, our results offer a practical roadmap for strengthening capacity and supporting career development.
- 25 August 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
“We do it because it matters”—From insight to impact when involving neuro-oncology caregivers in the design of a supportive intervention
Background: Persons with lived experiences are a valuable resource to ensure that support interventions are grounded in real-world needs and thereby become relevant, acceptable, and impactful. The aim of this study is 2-folded: (1) to design a supportive group-based intervention for caregivers of patients diagnosed with glioblastoma with user involvement and (2) to evaluate the user involvement process. Methods: An intervention development study using Patient and Public Involvement (PPI) engaged caregivers in the design of a supportive intervention for caregivers. The Workbook to Guide the Development of a Patient Engagement in Research Plan served as a guide for the PPI process and collaboration between a caregiver panel and the researcher team. The process was evaluated using a multi-methods approach, including quantitative and qualitative data. Results: A national panel of current- and bereaved caregivers (n = 10) was recruited from the Danish Brain Tumour Association. A multicomponent online intervention was developed during a 2-year PPI-process shaped by the panel members’ lived experiences. Participants evaluated engagement as highly meaningful, with an overall mean score of 94.9% (range 85.2%-100%). The qualitative findings supported the positive results, describing the process as well-structured, meaningful, and valuable for the participating caregivers. Conclusion: The study demonstrated successful engagement of neuro-oncology caregivers in a long-term, structured PPI process. Despite emotionally demanding life circumstances, including disease progression and bereavement, panel members consistently maintained their engagement in the panel. PPI was a resource-intensive process; however, the added value included enhancing relevance, strengthening population-targeted intervention design, and ensuring that lived experiences meaningfully shaped the supportive intervention.
- 25 August 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
“We do it because it matters”—From insight to impact when involving neuro-oncology caregivers in the design of a supportive intervention
Background: Persons with lived experiences are a valuable resource to ensure that support interventions are grounded in real-world needs and thereby become relevant, acceptable, and impactful. The aim of this study is 2-folded: (1) to design a supportive group-based intervention for caregivers of patients diagnosed with glioblastoma with user involvement and (2) to evaluate the user involvement process. Methods: An intervention development study using Patient and Public Involvement (PPI) engaged caregivers in the design of a supportive intervention for caregivers. The Workbook to Guide the Development of a Patient Engagement in Research Plan served as a guide for the PPI process and collaboration between a caregiver panel and the researcher team. The process was evaluated using a multi-methods approach, including quantitative and qualitative data. Results: A national panel of current- and bereaved caregivers (n = 10) was recruited from the Danish Brain Tumour Association. A multicomponent online intervention was developed during a 2-year PPI-process shaped by the panel members’ lived experiences. Participants evaluated engagement as highly meaningful, with an overall mean score of 94.9% (range 85.2%-100%). The qualitative findings supported the positive results, describing the process as well-structured, meaningful, and valuable for the participating caregivers. Conclusion: The study demonstrated successful engagement of neuro-oncology caregivers in a long-term, structured PPI process. Despite emotionally demanding life circumstances, including disease progression and bereavement, panel members consistently maintained their engagement in the panel. PPI was a resource-intensive process; however, the added value included enhancing relevance, strengthening population-targeted intervention design, and ensuring that lived experiences meaningfully shaped the supportive intervention.
- Open Access
- 11 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e81948
A Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study
Background: Caregivers to a person diagnosed with a glioblastoma often face significant responsibilities, balancing the demands of care with the complexities of the disease and treatment trajectory, while also coping with concerns and uncertainty of the future. Caregivers report unmet needs of information and support throughout the patient’s disease and treatment trajectory, and they may benefit from targeted supportive care interventions. Objective: The aim of this study is to develop, test, and evaluate the feasibility of a supportive group intervention among caregivers to patients diagnosed with a glioblastoma. Methods: The study consists of 3 phases with ongoing patient and public involvement (PPI). In the first phase, a systematic review will be carried out exploring the outcome of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. In the second phase, the design and development of the intervention will be conducted in cooperation with a panel of caregivers using PPI process. The third phase will include the feasibility and evaluation of the intervention. The study will be guided by the British Medical Research Council’s framework for developing complex interventions. The feasibility of the intervention will be tested in reference to relevant parameters. Quantitative data in terms of questionnaires will be analyzed using descriptive statistics, and qualitative evaluation interviews will be analyzed using thematic analysis. Results: A national panel of caregivers (N=10) has been established, and the final design of the intervention is currently developed through an ongoing PPI process. A total of 3 hospitals in Denmark have committed to participating in the recruitment for the feasibility study. Recruitment began in April 2025, and the SUGRI (Supportive Group Intervention for caregivers to patients diagnosed with a glioblastoma) intervention will undergo a feasibility assessment in a multicenter study starting in August 2025, with the final evaluation planned for April 2026. Conclusions: This study is expected to provide necessary insights to guide caregiver initiatives, ultimately improving support for caregivers within the neuro-oncology field. A supportive group intervention offered to the caregivers has the potential to address specific caregiver needs and strengthen their supportive network. Providing caregivers with support may enhance their perceived support, strengthen family functioning, and provide them with strategies to manage caregiving challenges, ultimately benefiting both caregivers and patients. Trial Registration: ClinicalTrials.gov NCT06869577; https://clinicaltrials.gov/study/NCT06869577 International Registered Report Identifier (IRRID): PRR1-10.2196/81948
- 11 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e81948
Open AccessA Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study
Background: Caregivers to a person diagnosed with a glioblastoma often face significant responsibilities, balancing the demands of care with the complexities of the disease and treatment trajectory, while also coping with concerns and uncertainty of the future. Caregivers report unmet needs of information and support throughout the patient’s disease and treatment trajectory, and they may benefit from targeted supportive care interventions. Objective: The aim of this study is to develop, test, and evaluate the feasibility of a supportive group intervention among caregivers to patients diagnosed with a glioblastoma. Methods: The study consists of 3 phases with ongoing patient and public involvement (PPI). In the first phase, a systematic review will be carried out exploring the outcome of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. In the second phase, the design and development of the intervention will be conducted in cooperation with a panel of caregivers using PPI process. The third phase will include the feasibility and evaluation of the intervention. The study will be guided by the British Medical Research Council’s framework for developing complex interventions. The feasibility of the intervention will be tested in reference to relevant parameters. Quantitative data in terms of questionnaires will be analyzed using descriptive statistics, and qualitative evaluation interviews will be analyzed using thematic analysis. Results: A national panel of caregivers (N=10) has been established, and the final design of the intervention is currently developed through an ongoing PPI process. A total of 3 hospitals in Denmark have committed to participating in the recruitment for the feasibility study. Recruitment began in April 2025, and the SUGRI (Supportive Group Intervention for caregivers to patients diagnosed with a glioblastoma) intervention will undergo a feasibility assessment in a multicenter study starting in August 2025, with the final evaluation planned for April 2026. Conclusions: This study is expected to provide necessary insights to guide caregiver initiatives, ultimately improving support for caregivers within the neuro-oncology field. A supportive group intervention offered to the caregivers has the potential to address specific caregiver needs and strengthen their supportive network. Providing caregivers with support may enhance their perceived support, strengthen family functioning, and provide them with strategies to manage caregiving challenges, ultimately benefiting both caregivers and patients. Trial Registration: ClinicalTrials.gov NCT06869577; https://clinicaltrials.gov/study/NCT06869577 International Registered Report Identifier (IRRID): PRR1-10.2196/81948
- Open Access
- 1 January 2026
- Published by Wiley in Nursing Research and Practice
- Vol. 2026 (1) , 2280006
Relatives’ Involvement in the Care Pathway of Patients With Acquired Brain Injury or Malignant Brain Tumour: An Observational Study
Aim: To explore how nurses involve the relatives of patients with acquired brain injury or malignant brain tumour and how this involvement unfolds in hospital ward settings. We focus on the contextual, interpersonal, and communicative dynamics that shape and mediate involvement. Design: A qualitative, exploratory design using nonparticipant field observation. Methods: Nineteen nonparticipant observations were conducted across seven units in four Danish hospital sites, covering the full clinical pathway from acute care to inpatient rehabilitation. Data were analysed using inductive content analysis following Graneheim and Lundman approach. Results: The analysis identified one overarching theme and three categories that illuminate how relative involvement is shaped in clinical practice. Relatives’ opportunities to be involved in the patient’s treatment and care were strongly influenced by the physical and organizational context, including the spatial layout of wards and the timing of clinical routines. Communicative practices ranged from one‐way information delivery to inclusive dialogues, affecting whether relatives were acknowledged and involved. The way nurses recognized relatives relationally, either as passive bystanders or as knowledgeable contributors, further shaped their role. Across all categories, a continuum of involvement emerged, ranging from complete absence to active partnership, reflecting how structural and interpersonal factors interact to enable or hinder meaningful engagement. Conclusion: Relative involvement is not consistently embedded in everyday clinical routines but varies depending on context, professional practice, and communicative approach. Involvement often depends on relatives taking initiative and is rarely proactively facilitated by nurses. However, when nurses are able to create structured, inclusive environments, relatives shift from peripheral observers to valued partners in care. Impact: This study contributes important observational knowledge to the field of family involvement in acute and complex care settings. The findings highlight the need for structured, context‐sensitive strategies that enable nurses to identify and support diverse forms of relative involvement. Such efforts are vital to ensure equitable engagement across different clinical settings and family constellations.
- 1 January 2026
- Published by Wiley in Nursing Research and Practice
- Vol. 2026 (1) , 2280006
Open AccessRelatives’ Involvement in the Care Pathway of Patients With Acquired Brain Injury or Malignant Brain Tumour: An Observational Study
Aim: To explore how nurses involve the relatives of patients with acquired brain injury or malignant brain tumour and how this involvement unfolds in hospital ward settings. We focus on the contextual, interpersonal, and communicative dynamics that shape and mediate involvement. Design: A qualitative, exploratory design using nonparticipant field observation. Methods: Nineteen nonparticipant observations were conducted across seven units in four Danish hospital sites, covering the full clinical pathway from acute care to inpatient rehabilitation. Data were analysed using inductive content analysis following Graneheim and Lundman approach. Results: The analysis identified one overarching theme and three categories that illuminate how relative involvement is shaped in clinical practice. Relatives’ opportunities to be involved in the patient’s treatment and care were strongly influenced by the physical and organizational context, including the spatial layout of wards and the timing of clinical routines. Communicative practices ranged from one‐way information delivery to inclusive dialogues, affecting whether relatives were acknowledged and involved. The way nurses recognized relatives relationally, either as passive bystanders or as knowledgeable contributors, further shaped their role. Across all categories, a continuum of involvement emerged, ranging from complete absence to active partnership, reflecting how structural and interpersonal factors interact to enable or hinder meaningful engagement. Conclusion: Relative involvement is not consistently embedded in everyday clinical routines but varies depending on context, professional practice, and communicative approach. Involvement often depends on relatives taking initiative and is rarely proactively facilitated by nurses. However, when nurses are able to create structured, inclusive environments, relatives shift from peripheral observers to valued partners in care. Impact: This study contributes important observational knowledge to the field of family involvement in acute and complex care settings. The findings highlight the need for structured, context‐sensitive strategies that enable nurses to identify and support diverse forms of relative involvement. Such efforts are vital to ensure equitable engagement across different clinical settings and family constellations.
- Open Access
- 17 October 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (11) , 1-14
Defining the symptoms of personality and behaviour changes in brain tumour patients and their impact on caregivers
Purpose: This study aimed to (i) identify how carers and healthcare professionals define and describe brain tumour–related personality and behaviour changes in adults and (ii) explore the impact of these changes on family carers. Methods: We conducted 22 semi-structured interviews with neuro-oncology healthcare professionals working in Australia and 13 interviews with current or bereaved carers in Australia and Denmark. Definition data were analysed deductively using the Diagnostic and Statistics Manual of Mental Disorders 5th Edition Text Revision (DSM-5-TR) Personality Change Due to Another Medical Condition diagnostic criteria, and inductively to uncover new ideas related to descriptions of brain tumour–related personality and behaviour changes perceived by carers and healthcare professionals. Inductive thematic analysis was conducted to develop themes exploring the impact of patient personality and behaviour changes on carers. Results: Two themes were identified from participants’ description of personality and behaviour changes associated with brain tumours: (i) variable presentation and multifactorial aetiology and (ii) manageable versus challenging changes. The specific features and symptoms of personality and behaviour changes reported by the sample are presented alongside the DSM-5-TR features of Personality Change Due to Another Medical Condition for clinical utility. Three themes were identified related to the impact of patient brain tumour–related personality and behaviour changes on carers: (i) grieving the person: “I don’t know who this person is anymore”; (ii) bearing the brunt of behavioural changes: “Happening behind closed doors”; and (iii) safety concerns and aggression: “I didn’t know what was going to happen next”. The three main themes were further elaborated through corresponding subthemes. Conclusions: This study highlights the nuances and complexity in conceptualising personality changes in patients with a brain tumour and the grief, isolation, and safety concerns experienced by carers. Brain tumour–related aggression was identified as a significant concern by both healthcare professionals and carers, lacking clinical guidelines internationally for managing violence and aggression in this population. Future research is required to test interventions and support for safeguarding and risk management for patients and their family members.
- 17 October 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (11) , 1-14
Open AccessDefining the symptoms of personality and behaviour changes in brain tumour patients and their impact on caregivers
Purpose: This study aimed to (i) identify how carers and healthcare professionals define and describe brain tumour–related personality and behaviour changes in adults and (ii) explore the impact of these changes on family carers. Methods: We conducted 22 semi-structured interviews with neuro-oncology healthcare professionals working in Australia and 13 interviews with current or bereaved carers in Australia and Denmark. Definition data were analysed deductively using the Diagnostic and Statistics Manual of Mental Disorders 5th Edition Text Revision (DSM-5-TR) Personality Change Due to Another Medical Condition diagnostic criteria, and inductively to uncover new ideas related to descriptions of brain tumour–related personality and behaviour changes perceived by carers and healthcare professionals. Inductive thematic analysis was conducted to develop themes exploring the impact of patient personality and behaviour changes on carers. Results: Two themes were identified from participants’ description of personality and behaviour changes associated with brain tumours: (i) variable presentation and multifactorial aetiology and (ii) manageable versus challenging changes. The specific features and symptoms of personality and behaviour changes reported by the sample are presented alongside the DSM-5-TR features of Personality Change Due to Another Medical Condition for clinical utility. Three themes were identified related to the impact of patient brain tumour–related personality and behaviour changes on carers: (i) grieving the person: “I don’t know who this person is anymore”; (ii) bearing the brunt of behavioural changes: “Happening behind closed doors”; and (iii) safety concerns and aggression: “I didn’t know what was going to happen next”. The three main themes were further elaborated through corresponding subthemes. Conclusions: This study highlights the nuances and complexity in conceptualising personality changes in patients with a brain tumour and the grief, isolation, and safety concerns experienced by carers. Brain tumour–related aggression was identified as a significant concern by both healthcare professionals and carers, lacking clinical guidelines internationally for managing violence and aggression in this population. Future research is required to test interventions and support for safeguarding and risk management for patients and their family members.
- Open Access
- 6 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study (Preprint)
BACKGROUND Caregivers to a person diagnosed with a glioblastoma often face significant responsibilities, balancing the demands of care with the complexities of the disease and treatment trajectory, while also coping with concerns and uncertainty of the future. Caregivers report unmet needs of information and support throughout the patient’s disease and treatment trajectory, and they may benefit from targeted supportive care interventions. OBJECTIVE The aim of this study is to develop, test, and evaluate the feasibility of a supportive group intervention among caregivers to patients diagnosed with a glioblastoma. METHODS The study consists of 3 phases with ongoing patient and public involvement (PPI). In the first phase, a systematic review will be carried out exploring the outcome of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. In the second phase, the design and development of the intervention will be conducted in cooperation with a panel of caregivers using PPI process. The third phase will include the feasibility and evaluation of the intervention. The study will be guided by the British Medical Research Council’s framework for developing complex interventions. The feasibility of the intervention will be tested in reference to relevant parameters. Quantitative data in terms of questionnaires will be analyzed using descriptive statistics, and qualitative evaluation interviews will be analyzed using thematic analysis. RESULTS A national panel of caregivers (N=10) has been established, and the final design of the intervention is currently developed through an ongoing PPI process. A total of 3 hospitals in Denmark have committed to participating in the recruitment for the feasibility study. Recruitment began in April 2025, and the SUGRI (Supportive Group Intervention for caregivers to patients diagnosed with a glioblastoma) intervention will undergo a feasibility assessment in a multicenter study starting in August 2025, with the final evaluation planned for April 2026. CONCLUSIONS This study is expected to provide necessary insights to guide caregiver initiatives, ultimately improving support for caregivers within the neuro-oncology field. A supportive group intervention offered to the caregivers has the potential to address specific caregiver needs and strengthen their supportive network. Providing caregivers with support may enhance their perceived support, strengthen family functioning, and provide them with strategies to manage caregiving challenges, ultimately benefiting both caregivers and patients. CLINICALTRIAL ClinicalTrials.gov NCT06869577; https://clinicaltrials.gov/study/NCT06869577 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/81948
- 6 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study (Preprint)
BACKGROUND Caregivers to a person diagnosed with a glioblastoma often face significant responsibilities, balancing the demands of care with the complexities of the disease and treatment trajectory, while also coping with concerns and uncertainty of the future. Caregivers report unmet needs of information and support throughout the patient’s disease and treatment trajectory, and they may benefit from targeted supportive care interventions. OBJECTIVE The aim of this study is to develop, test, and evaluate the feasibility of a supportive group intervention among caregivers to patients diagnosed with a glioblastoma. METHODS The study consists of 3 phases with ongoing patient and public involvement (PPI). In the first phase, a systematic review will be carried out exploring the outcome of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. In the second phase, the design and development of the intervention will be conducted in cooperation with a panel of caregivers using PPI process. The third phase will include the feasibility and evaluation of the intervention. The study will be guided by the British Medical Research Council’s framework for developing complex interventions. The feasibility of the intervention will be tested in reference to relevant parameters. Quantitative data in terms of questionnaires will be analyzed using descriptive statistics, and qualitative evaluation interviews will be analyzed using thematic analysis. RESULTS A national panel of caregivers (N=10) has been established, and the final design of the intervention is currently developed through an ongoing PPI process. A total of 3 hospitals in Denmark have committed to participating in the recruitment for the feasibility study. Recruitment began in April 2025, and the SUGRI (Supportive Group Intervention for caregivers to patients diagnosed with a glioblastoma) intervention will undergo a feasibility assessment in a multicenter study starting in August 2025, with the final evaluation planned for April 2026. CONCLUSIONS This study is expected to provide necessary insights to guide caregiver initiatives, ultimately improving support for caregivers within the neuro-oncology field. A supportive group intervention offered to the caregivers has the potential to address specific caregiver needs and strengthen their supportive network. Providing caregivers with support may enhance their perceived support, strengthen family functioning, and provide them with strategies to manage caregiving challenges, ultimately benefiting both caregivers and patients. CLINICALTRIAL ClinicalTrials.gov NCT06869577; https://clinicaltrials.gov/study/NCT06869577 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/81948
- 18 July 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 12 (6) , 983-997
Group-based interventions for caregivers to patients diagnosed with a brain tumor: A systematic review
Background: Individuals diagnosed with a primary brain tumor often depend on practical assistance and emotional support from family and social network. Supportive care interventions are therefore of importance to informal caregivers. The aim of this review was to identify and explore available evidence of outcomes of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. Methods: A systematic review was conducted following the PRISMA guidelines. Six databases: PubMed, Embase, Web of Science, Emcare, Cochrane Library, and PsycINFO were searched for peer-reviewed publications. Quality of included publications was assessed by the Mixed-Methods Appraisal Tool and data synthesis followed Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. Results: Five eligible publications were identified, published between 2007 and 2021, originating from Australia, Austria, Canada, Denmark, and Germany. Supportive group interventions for caregivers to patients diagnosed with a primary brain tumor were considered feasible, with outcomes evaluated positively in 5 publications. The group interaction within a supportive intervention created a trusted environment for caregivers to share their experiences. Group interactions represented an essential source of support and information to manage the caregiver role. Shared acknowledgment of their new role boosted caregivers’ confidence in their abilities to deliver care. Conclusion: Interventions seeking to facilitate interaction between caregivers may provide an extra supportive resource for the caregivers. Nevertheless, further research is necessary to ascertain the optimal setting, content, and timing for providing caregivers a supportive group intervention.
- 18 July 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 12 (6) , 983-997
Group-based interventions for caregivers to patients diagnosed with a brain tumor: A systematic review
Background: Individuals diagnosed with a primary brain tumor often depend on practical assistance and emotional support from family and social network. Supportive care interventions are therefore of importance to informal caregivers. The aim of this review was to identify and explore available evidence of outcomes of supportive group interventions for caregivers to patients diagnosed with a primary brain tumor. Methods: A systematic review was conducted following the PRISMA guidelines. Six databases: PubMed, Embase, Web of Science, Emcare, Cochrane Library, and PsycINFO were searched for peer-reviewed publications. Quality of included publications was assessed by the Mixed-Methods Appraisal Tool and data synthesis followed Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. Results: Five eligible publications were identified, published between 2007 and 2021, originating from Australia, Austria, Canada, Denmark, and Germany. Supportive group interventions for caregivers to patients diagnosed with a primary brain tumor were considered feasible, with outcomes evaluated positively in 5 publications. The group interaction within a supportive intervention created a trusted environment for caregivers to share their experiences. Group interactions represented an essential source of support and information to manage the caregiver role. Shared acknowledgment of their new role boosted caregivers’ confidence in their abilities to deliver care. Conclusion: Interventions seeking to facilitate interaction between caregivers may provide an extra supportive resource for the caregivers. Nevertheless, further research is necessary to ascertain the optimal setting, content, and timing for providing caregivers a supportive group intervention.
- Open Access
- 16 July 2025
- Published by Wiley in Psycho-Oncology
- Vol. 34 (7) , e70231
Unveiling the Unspoken: Exploring Taboo Thoughts and Difficult Experiences Among Carers of People With Brain Cancer
Objective: The primary objective of this research was to explore the rarely discussed, often unspoken, taboo thoughts and difficult emotions experienced by carers who support individuals with brain tumour related personality and behaviour changes. A secondary aim of this study was to examine coping strategies used by these carers.Methods: A qualitative interview study was conducted with participants from Australia (n = 7) and Denmark (n = 6) (92% female, aged 42–68 years) who had been or were current carers for someone with a primary malignant brain tumour who was displaying personality changes. Semi‐structured interviews were conducted. Using thematic analysis, key themes were identified.Results: Four key themes related to carers' unspoken thoughts were identified: (1) Staying safe: “His aggression was just out of this world”; (2) Conflicting and complex emotions: “I love him for who he was”; (3) Wishing for the end with grief and relief and (4) Experiences of patient death and end of life treatment decisions. Carers described five coping strategies: (1) Commitment to care; (2) Life alongside carer role; (3) Acceptance of circumstances; (4) Self‐silencing; and (5) Information seeking and safety planning.Conclusions: The relentless nature of this disease and potential treatment side effects places an immense burden on carers that often is unspoken. The findings highlight the importance of healthcare professionals providing support for carers, in asking about their experience, and appropriate assessment and management of brain tumour related aggression. The results hold the potential to inform targeted interventions for the unique challenges faced by carers supporting someone with brain tumour related personality and behaviour changes.
- 16 July 2025
- Published by Wiley in Psycho-Oncology
- Vol. 34 (7) , e70231
Open AccessUnveiling the Unspoken: Exploring Taboo Thoughts and Difficult Experiences Among Carers of People With Brain Cancer
Objective: The primary objective of this research was to explore the rarely discussed, often unspoken, taboo thoughts and difficult emotions experienced by carers who support individuals with brain tumour related personality and behaviour changes. A secondary aim of this study was to examine coping strategies used by these carers.Methods: A qualitative interview study was conducted with participants from Australia (n = 7) and Denmark (n = 6) (92% female, aged 42–68 years) who had been or were current carers for someone with a primary malignant brain tumour who was displaying personality changes. Semi‐structured interviews were conducted. Using thematic analysis, key themes were identified.Results: Four key themes related to carers' unspoken thoughts were identified: (1) Staying safe: “His aggression was just out of this world”; (2) Conflicting and complex emotions: “I love him for who he was”; (3) Wishing for the end with grief and relief and (4) Experiences of patient death and end of life treatment decisions. Carers described five coping strategies: (1) Commitment to care; (2) Life alongside carer role; (3) Acceptance of circumstances; (4) Self‐silencing; and (5) Information seeking and safety planning.Conclusions: The relentless nature of this disease and potential treatment side effects places an immense burden on carers that often is unspoken. The findings highlight the importance of healthcare professionals providing support for carers, in asking about their experience, and appropriate assessment and management of brain tumour related aggression. The results hold the potential to inform targeted interventions for the unique challenges faced by carers supporting someone with brain tumour related personality and behaviour changes.
- Open Access
- 30 July 2024
- Published by Wiley in Journal of Clinical Nursing
- Vol. 34 (3) , 784-794
Interventions facilitating the involvement of relatives of patients with acquired brain injury or malignant brain tumour: A scoping review
Aim: To identify and map the evidence on interventions facilitating the involvement of relatives of patients with an acquired brain injury (ABI) or a malignant brain tumour (MBT).Background: An ABI or a MBT are severe diseases that have profound impact on the lives of patients and their relatives. The well‐being of the patient may be deteriorated, and relatives may experience a new role and changing caregiving tasks. Involvement of relatives seems essential, and there is a need for identifying interventions facilitating the involvement.Design: Scoping review.Methods: The Joanna Briggs Institute methodology was used in this review and the review was reported in accordance with the PRISMA extension for scoping reviews.Data Sources: The literature search was conducted in MEDLINE, Embase, CINAHL and Cochrane Library. Reference lists of included studies, Google Scholar and Web of Science were also searched.Results: In total, 46 studies were included of which 36 (78%) involved patients with stroke. Median duration of study interventions were 8 weeks, and nurses were involved as providers of the intervention in 23 (50%) studies. Thirty (65%) studies used a multicomponent intervention. Thirty‐five unique outcomes were identified using 60 unique outcome measurements.Conclusion: Interventions facilitating the involvement of relatives differed importantly in key characteristics of study interventions, and in relation to the context in which they were used. There was no consensus regarding choice of outcomes and outcome measurements. Our results highlight the complexity of interventions in this field.Implications for the Profession and/or Patient Care: To our knowledge this is the first scoping review examining interventions facilitating the involvement of relatives of patients with an acquired brain injury or a malignant brain tumour. This review suggests a clear definition of ‘involvement’ in future research and there is a need of development of a core outcome set for use in interventions facilitating the involvement.Reporting Method: The scoping review was reported in accordance with the PRISMA extension for scoping reviews.No Patient or Public Contribution: The authors decided to undertake this scoping review without patient and public contribution. However, the protocol was published prior to review conduct and available to the public but we did not receive any comments on it.
- 30 July 2024
- Published by Wiley in Journal of Clinical Nursing
- Vol. 34 (3) , 784-794
Open AccessInterventions facilitating the involvement of relatives of patients with acquired brain injury or malignant brain tumour: A scoping review
Aim: To identify and map the evidence on interventions facilitating the involvement of relatives of patients with an acquired brain injury (ABI) or a malignant brain tumour (MBT).Background: An ABI or a MBT are severe diseases that have profound impact on the lives of patients and their relatives. The well‐being of the patient may be deteriorated, and relatives may experience a new role and changing caregiving tasks. Involvement of relatives seems essential, and there is a need for identifying interventions facilitating the involvement.Design: Scoping review.Methods: The Joanna Briggs Institute methodology was used in this review and the review was reported in accordance with the PRISMA extension for scoping reviews.Data Sources: The literature search was conducted in MEDLINE, Embase, CINAHL and Cochrane Library. Reference lists of included studies, Google Scholar and Web of Science were also searched.Results: In total, 46 studies were included of which 36 (78%) involved patients with stroke. Median duration of study interventions were 8 weeks, and nurses were involved as providers of the intervention in 23 (50%) studies. Thirty (65%) studies used a multicomponent intervention. Thirty‐five unique outcomes were identified using 60 unique outcome measurements.Conclusion: Interventions facilitating the involvement of relatives differed importantly in key characteristics of study interventions, and in relation to the context in which they were used. There was no consensus regarding choice of outcomes and outcome measurements. Our results highlight the complexity of interventions in this field.Implications for the Profession and/or Patient Care: To our knowledge this is the first scoping review examining interventions facilitating the involvement of relatives of patients with an acquired brain injury or a malignant brain tumour. This review suggests a clear definition of ‘involvement’ in future research and there is a need of development of a core outcome set for use in interventions facilitating the involvement.Reporting Method: The scoping review was reported in accordance with the PRISMA extension for scoping reviews.No Patient or Public Contribution: The authors decided to undertake this scoping review without patient and public contribution. However, the protocol was published prior to review conduct and available to the public but we did not receive any comments on it.
- 15 March 2024
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 11 (4) , 484-493
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectives
Background: Neuro-oncology patients and caregivers should have equitable access to rehabilitation, supportive-, and palliative care. To investigate existing issues and potential solutions, we surveyed neuro-oncology professionals to explore current barriers and facilitators to screening patients’ needs and referral to services. Methods: Members of the European Association of Neuro-Oncology and the European Organisation for Research and Treatment of Cancer Brain Tumor Group (EORTC-BTG) were invited to complete a 39-item online questionnaire covering the availability of services, screening, and referral practice. Responses were analyzed descriptively; associations between sociodemographic/clinical variables and screening/referral practice were explored. Results: In total, 103 participants completed the survey (67% women and 57% medical doctors). Fifteen professions from 23 countries were represented. Various rehabilitation, supportive-, and palliative care services were available yet rated “inadequate” by 21–37% of participants. Most respondents with a clinical role (n = 94) declare to screen (78%) and to refer (83%) their patients routinely for physical/cognitive/emotional issues. Survey completers (n = 103) indicated the main reasons for not screening/referring were (1) lack of suitable referral options (50%); (2) shortage of healthcare professionals (48%); and (3) long waiting lists (42%). To improve service provision, respondents suggested there is a need for education about neuro-oncology-specific issues (75%), improving the availability of services (65%) and staff (64%), developing international guidelines (64%), and strengthening the existing evidence-base for rehabilitation (60%). Conclusions: Detecting and managing neuro-oncology patients’ and caregivers’ rehabilitation, supportive,- and palliative care needs can be improved. Better international collaboration can help address healthcare disparities.
- 15 March 2024
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 11 (4) , 484-493
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectives
Background: Neuro-oncology patients and caregivers should have equitable access to rehabilitation, supportive-, and palliative care. To investigate existing issues and potential solutions, we surveyed neuro-oncology professionals to explore current barriers and facilitators to screening patients’ needs and referral to services. Methods: Members of the European Association of Neuro-Oncology and the European Organisation for Research and Treatment of Cancer Brain Tumor Group (EORTC-BTG) were invited to complete a 39-item online questionnaire covering the availability of services, screening, and referral practice. Responses were analyzed descriptively; associations between sociodemographic/clinical variables and screening/referral practice were explored. Results: In total, 103 participants completed the survey (67% women and 57% medical doctors). Fifteen professions from 23 countries were represented. Various rehabilitation, supportive-, and palliative care services were available yet rated “inadequate” by 21–37% of participants. Most respondents with a clinical role (n = 94) declare to screen (78%) and to refer (83%) their patients routinely for physical/cognitive/emotional issues. Survey completers (n = 103) indicated the main reasons for not screening/referring were (1) lack of suitable referral options (50%); (2) shortage of healthcare professionals (48%); and (3) long waiting lists (42%). To improve service provision, respondents suggested there is a need for education about neuro-oncology-specific issues (75%), improving the availability of services (65%) and staff (64%), developing international guidelines (64%), and strengthening the existing evidence-base for rehabilitation (60%). Conclusions: Detecting and managing neuro-oncology patients’ and caregivers’ rehabilitation, supportive,- and palliative care needs can be improved. Better international collaboration can help address healthcare disparities.